Patents by Inventor Torben Elhauge

Torben Elhauge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES
    Publication number: 20230073256
    Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.
    Type: Application
    Filed: August 18, 2022
    Publication date: March 9, 2023
    Inventors: Nikolaj SKAK, Karsten LINDHARDT, Torben ELHAUGE, Martin Rex OLSEN
  • Oral delivery of active drug substances
    Patent number: 11452851
    Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: September 27, 2022
    Assignee: Biograil ApS
    Inventors: Nikolaj Skak, Karsten Lindhardt, Torben Elhauge, Martin Rex Olsen
  • ORAL DELIVERY OF ACTIVE DRUG SUBSTANCES
    Publication number: 20210290918
    Abstract: The present disclosure relates to a delivery device capable of delivering compositions. In some embodiments, the delivery device may deliver compositions to the gastrointestinal tract. In some embodiments, the compositions contain active drug substances. In some embodiments, the active drug substances are low permeable active drug substances.
    Type: Application
    Filed: December 18, 2018
    Publication date: September 23, 2021
    Inventors: Nikolaj SKAK, Karsten LINDHARDT, Torben ELHAUGE, Martin Rex OLSEN
  • ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE
    Publication number: 20170333354
    Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.
    Type: Application
    Filed: December 8, 2016
    Publication date: November 23, 2017
    Applicant: Egalet Ltd.
    Inventors: Peter Holm Tygesen, Karsten Lindhardt, Martin Rex Olsen, Gina Engslev Fischer, Jan Martin Overgard, Georg Boye, Nikolaj Skak, Torben Elhauge
  • ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE
    Publication number: 20170181974
    Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 29, 2017
    Applicant: Egalet Ltd.
    Inventors: Peter Holm Tygesen, Karsten Lindhardt, Martin Rex Olsen, Gina Engslev Fischer, Jan Martin Overgard, Georg Boye, Nikolaj Skak, Torben Elhauge
  • Abuse deterrent pharmaceutical compositions for controlled release
    Patent number: 9549899
    Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.
    Type: Grant
    Filed: July 1, 2013
    Date of Patent: January 24, 2017
    Assignee: EGALET LTD.
    Inventors: Peter Holm Tygesen, Karsten Lindhardt, Martin Rex Olsen, Gina Engslev Fischer, Jan Martin Overgard, Georg Boye, Nikolaj Skak, Torben Elhauge
  • Abuse-deterrent pharmaceutical compositions for controlled release
    Patent number: 9044402
    Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: June 2, 2015
    Assignee: EGALET LTD.
    Inventors: Peter Holm Tygesen, Karsten Lindhardt, Martin Rex Olsen, Gina Engslev Fischer, Jan Martin Overgard, Georg Boye, Nikolaj Skak, Torben Elhauge
  • ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE
    Publication number: 20140220126
    Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.
    Type: Application
    Filed: April 10, 2014
    Publication date: August 7, 2014
    Applicant: EGALET LTD.
    Inventors: Peter Holm Tygesen, Karsten Lindhardt, Martin Rex Olsen, Gina Engslev Fischer, Jan Martin Overgard, Georg Boye, Nikolaj Skak, Torben Elhauge
  • ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED RELEASE
    Publication number: 20140010873
    Abstract: The present disclosure relates to pharmaceutical compositions that are abuse resistant and may also provide controlled release. The present disclosure also relates to the use of pharmaceutical compositions in the treatment of pain.
    Type: Application
    Filed: July 1, 2013
    Publication date: January 9, 2014
    Inventors: Peter Holm Tygesen, Karsten Lindhardt, Martin Rex Olsen, Gina Engslev Fischer, Jan Martin Overgard, Georg Boye, Nikolaj Skak, Torben Elhauge